Praxis Precision Medicines
Trade Praxis Precision Medicines 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus.
PRAX Key Statistics
Stock Snapshot
As of today, Praxis Precision Medicines(PRAX) shares are valued at $311.71. The company's market cap stands at 8.52B, with a P/E ratio of -24.16.
On 2026-01-24, Praxis Precision Medicines(PRAX) stock moved within a range of $298.38 to $318.00. With shares now at $311.71, the stock is trading +4.5% above its intraday low and -2.0% below the session's peak.
Trading volume for Praxis Precision Medicines(PRAX) stock has reached 551.76K, versus its average volume of 595.41K.
Over the past 52 weeks, Praxis Precision Medicines(PRAX) stock has traded between a high of $326.91 and a low of $26.70.
Over the past 52 weeks, Praxis Precision Medicines(PRAX) stock has traded between a high of $326.91 and a low of $26.70.
Analyst ratings
93%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.